IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 16 February 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01737-06v1
75/5/2381    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smedley, J. G.
Right arrow Articles by McClane, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smedley, J. G., III
Right arrow Articles by McClane, B. A.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.01737-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Identification of a Pre-Pore Large Complex Stage in the Mechanism of Action of Clostridium perfringens Enterotoxin

James G. Smedley III, Francisco A. Uzal, and Bruce A. McClane*

Department of Molecular Genetics and Biochemistry; Molecular Virology and Microbiology Graduate Program; California Animal Health and Food Safety Laboratory, University of California, Davis

* To whom correspondence should be addressed. Email: bamcc{at}pitt.edu.


   Abstract

Clostridium perfringens enterotoxin (CPE) is the etiological agent of the 3rd most common food-borne illness in the U.S.A. The enteropathogenic effects of CPE result from formation of large CPE-containing complexes in eukaryotic cell membranes. Formation of these ~155 and ~200 kDa complexes coincides with plasma membrane permeability changes in eukaryotic cells, causing a Ca2+ influx that drives cell death pathways. CPE contains a stretch of amino acids (residues 81-106) that alternates markedly in side chain polarity (a pattern shared by the transmembrane domains of the {beta}-barrel pore-forming toxin family). The goal of this study, therefore, was to investigate whether this CPE region is involved in pore formation. Complete deletion of the CPE 81-106 region produced a CPE variant that was non-cytotoxic for Caco-2 cells and was unable to form CPE pores. However, this variant maintained the ability to form the ~155 kDa large complex. This large complex appears to be a pre-pore present on the plasma membrane surface since it showed greater susceptibility to proteases, increased complex instability, and a higher degree of dissociation from membranes when compared to the large complex formed by rCPE. When a D48A mutation was engineered into this pre-pore forming CPE variant, the resultant variant was unable to form any pre-pore ~155 kDa large complex. Collectively these findings reveal a new step in CPE action, whereby receptor binding is followed by formation of a pre-pore large complex which then inserts into membranes to form a pore.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.